Dräger Fabius Series User Manual

Page 31 / 38
1 Initial situation and consequences
Initial situation according to the customer letter “COVID-19: Usage of Dräger anesthesia devices for long-
term ventilation”. That means:
 high fresh gas flow 1.5xMV
 no volatile anesthetic agent
 soda lime at the device
 active AGS
 manual breathing bag connected
 mechanical filters with HME connected
Potential impact:
 High gas supply consumption according to the set fresh gas flow (150% of the minute volume)
 Compressed air consumption due to the active AGS additional to the fresh gas flow
 IV medication needed for sedation
 Low soda lime consumption
 Drying out of the soda lime, but no patient harm (e.g. compound formation), as no volatile
anesthetic agent must be used
 No room air contamination
 Reduced humidity in the circle system
2 Shortage in IV medication for sedation
 Use alternative IV drugs for sedation
 Avoid usage of volatile anesthetic agents
3 Central gas supply shortage
 Reduce the fresh gas flow, see chapter 12
 If possible, connect gas cylinders to the device
 If one gas (O
2
or AIR) fails, fresh gas supply can continue with the remaining gas. However, it
is not possiblbe to adjust the fresh gas O
2
concentration any longer.

Dräger Fabius Series Specifications

General

Type	Anesthesia Workstation
Manufacturer	Dräger
Ventilation Modes	SIMV
Flow Control	Electronic
Tidal Volume Range	20 to 1400 mL (model dependent)
Respiratory Rate	4 to 60 breaths/min
PEEP	0-20 cmH2O
Gas Supply	O2, Air, N2O
Vaporizer Mounts	2
Monitoring	O2, CO2, N2O
Dimensions	Varies by model
Weight	Varies by model
Model	Fabius Series
Category	Anesthesia